Molecule intelOpportunity: ModerateEssentialCrowded market

Caffeine

139 brands · 100 companies · product forms

ATC: D11AX26, N06BC01

Opportunity snapshot

Launch attractiveness
35
Market saturation
98
Price room
100
Regulatory risk
0
139
brands
100
companies
Rs 439
median price
24
price points
973.6x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 55.26
MedianRs 439
Most expensiveRs 53,801.17
Spread973.6×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 973.60x across 24 trusted points (Rs 55.26-53801.17). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 8 live products for Caffeine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(2) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

100 canonical companies and 139 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 973.60x across 24 trusted points (Rs 55.26-53801.17). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.